COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing’s Sarcoma

Table 5

Relationship between the expression level of COL3A1 and clinical characteristics in ES.

Characteristic	Low expression of COL3A1	High expression of COL3A1
	50	51
Metastasis, (%)			0.686
No	39 (38.6%)	37 (36.6%)
Yes	11 (10.9%)	14 (13.9%)
Tumor region, (%)			0.920
Distal	19 (29.7%)	17 (26.6%)
Other	1 (1.6%)	2 (3.1%)
Proximal	13 (20.3%)	12 (18.8%)
Proximal and distal	0 (0%)	0 (0%)
Age, (%)			0.371
<18	41 (40.6%)	37 (36.6%)
≥18	9 (8.9%)	14 (13.9%)
Gender, (%)			0.089
Female	25 (24.8%)	16 (15.8%)
Male	25 (24.8%)	35 (34.7%)
Race, (%)
American Indian or Alaska Native	0 (0%)	1 (1.3%)
Asian	3 (3.9%)	4 (5.3%)
Black or African American	3 (3.9%)	7 (9.2%)
Native Hawaiian or other Pacific Islander	0 (0%)	0 (0%)
White	31 (40.8%)	27 (35.5%)
Age, median (IQR)	15.12 (12.62, 17.33)	15.1 (12.12, 18.41)	0.973